Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial

Research output: Contribution to journalArticlepeer-review

51 Citations (Scopus)
27 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial'. Together they form a unique fingerprint.

Medicine & Life Sciences